Counterfeit bulk drugs
hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000
United States
Congress.
House.
Committee on Commerce.
Subcommittee on Oversight and Investigations.
creator
text
dcu
Washington
U.S. G.P.O.
For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.
2000
monographic
eng
iii, 423 pages : illustrations ; 24 cm
"Serial no. 106-164."
Shipping list no not available.
CRDP Program record.
Microfiche. Washington : U.S. G.P.O., 2001. 5 microfiches : negative.
n-us---
Drugs
Inspection
United States
Drugs
Standards
United States
Drug adulteration
Government policy
United States
Pharmaceutical industry
United States
Quality control
Product counterfeiting
United States
Y 4.C 73/8:106-164
Y 4.C 73/8:106-164
Counterfeit bulk drugs
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
(OCoLC)852783298
Counterfeit bulk drugs
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
(OCoLC)503594555
FPS
010810
20180511125017.0
ocm47755624
eng